BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33351190)

  • 21. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Basis for Draxin-Modulated Axon Guidance and Fasciculation by Netrin-1 through DCC.
    Liu Y; Bhowmick T; Liu Y; Gao X; Mertens HDT; Svergun DI; Xiao J; Zhang Y; Wang JH; Meijers R
    Neuron; 2018 Mar; 97(6):1261-1267.e4. PubMed ID: 29503192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversing a model of Parkinson's disease with in situ converted nigral neurons.
    Qian H; Kang X; Hu J; Zhang D; Liang Z; Meng F; Zhang X; Xue Y; Maimon R; Dowdy SF; Devaraj NK; Zhou Z; Mobley WC; Cleveland DW; Fu XD
    Nature; 2020 Jun; 582(7813):550-556. PubMed ID: 32581380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson's Disease?
    von Linstow CU; DeLano-Taylor M; Kordower JH; Brundin P
    J Parkinsons Dis; 2020; 10(2):405-411. PubMed ID: 31958098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
    Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
    Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF.
    Nam JH; Park ES; Won SY; Lee YA; Kim KI; Jeong JY; Baek JY; Cho EJ; Jin M; Chung YC; Lee BD; Kim SH; Kim EG; Byun K; Lee B; Woo DH; Lee CJ; Kim SR; Bok E; Kim YS; Ahn TB; Ko HW; Brahmachari S; Pletinkova O; Troconso JC; Dawson VL; Dawson TM; Jin BK
    Brain; 2015 Dec; 138(Pt 12):3610-22. PubMed ID: 26490328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Antiapoptosis Effect of Netrin-1 on Ischemic Stroke and Its Molecular Mechanism under Deleted in Colon Cancer/Extracellular Signal-Regulated Kinase Signaling Pathway.
    Wang K; Rong L; Wei X; Zhang Q
    Biomed Res Int; 2020; 2020():8855949. PubMed ID: 33274229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DCC-related developmental effects of abused- versus therapeutic-like amphetamine doses in adolescence.
    Cuesta S; Restrepo-Lozano JM; Popescu C; He S; Reynolds LM; Israel S; Hernandez G; Rais R; Slusher BS; Flores C
    Addict Biol; 2020 Jul; 25(4):e12791. PubMed ID: 31192517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Netrin-1-Derived Peptide Enhances Protection against Neuronal Death and Mitigates of Intracerebral Hemorrhage in Mice.
    Liu L; Liu KJ; Cao JB; Yang J; Yu HL; He XX; He ZX; Zhu XJ
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Netrin-1-like-immunoreactivity Coexpresses With DCC and Has a Differential Level in the Myenteric Cholinergic and Nitrergic Neurons of the Adult Mouse Colon.
    Ko SY; Price JT; Blatch GL; Nurgali K
    J Histochem Cytochem; 2019 May; 67(5):335-349. PubMed ID: 30576266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.
    Saal KA; Koch JC; Tatenhorst L; Szegő EM; Ribas VT; Michel U; Bähr M; Tönges L; Lingor P
    Neurobiol Dis; 2015 Jan; 73():150-62. PubMed ID: 25283984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
    Li J; Wang LN; Xiao HL; Li X; Yang JJ
    Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration.
    Gordon R; Neal ML; Luo J; Langley MR; Harischandra DS; Panicker N; Charli A; Jin H; Anantharam V; Woodruff TM; Zhou QY; Kanthasamy AG; Kanthasamy A
    Nat Commun; 2016 Oct; 7():12932. PubMed ID: 27703142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Netrin-1 contributes to peripheral nerve injury induced neuropathic pain via regulating phosphatidylinositol 4-kinase IIa in the spinal cord dorsal horn in mice.
    Li J; Wang G; Weng Y; Ding M; Yu W
    Neurosci Lett; 2020 Sep; 735():135161. PubMed ID: 32553804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.